Mitogen Induced Blood Lymphocyte DNA Synthesis as a Prognostic Indicator in Patients with Non-Hodgkin's Lymphomas in Clinical Remission

References

• Advani S. H., Dinshaw K. A., Nair C. N., Gopal R., Talwalkar G. V., Iyyer Y. S., Bhatia H. M., Desai P. B. Immune dysfunction in non-Hodgkin's lymphoma. Cancer 1980; 45: 2843
   PubMedGoogle Scholar
• Andersson T. C., Jones S. E., Soehnlen B. J., Moon T. E., Griffith K., Stanley P. Immunocompetence and malignant lymphoma. Immunologic status before therapy. Cancer 1981; 48: 2702
   PubMedGoogle Scholar
• Bagley C. M., DeVita V. T., Jr, Berard C. W., Canellos G. P. Advanced lymphosarcoma. Intensive cyclical combination therapy with cyclophosphamide, vincristine and prednisolone. Ann. intern. Med. 1972; 76: 227
   PubMed Web of Science ®Google Scholar
• Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res. 1971; 31: 1860
   PubMed Web of Science ®Google Scholar
• DeVita V. T., Jr, Canellos G. P., Chabner B., Hubbard S. P., Schein P., Young R. C. Advanced diffuse histiocytic lymphoma. A potentially curable disease. Lancet 1975; 1: 248
   PubMed Web of Science ®Google Scholar
• Fisher R. I., DeVita V. T., Jr, Johnson B. L., Simon R., Young R. C. Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy. Amer. J. Med. 1977; 63: 177
   PubMed Web of Science ®Google Scholar
• Holm G., Pettersson D., Mellstedt H., Hedfors E., Bloth B. Lymphocyte subpopulations in peripheral blood of healthy persons. Characterization by surface markers and lack of selection during purification. Clin. Exp. Immunol. 1975; 20: 443
   Web of Science ®Google Scholar
• Hunter C. P., Tannenbaum H., Churchill W. H., Moloney W. C., Schur P. H. Immunologic abnormalities in patients with malignant lymphoprolierative diseases. J. Nat. Cancer Inst. 1977; 58: 1185
   PubMedGoogle Scholar
• Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming non-immune rosettes with sheep red blood cells. J. exp. Med. 1972; 136: 207
   PubMed Web of Science ®Google Scholar
• Jones S. E., Griffith K., Dombrowski P., Gaines J. A. Immunodeficiency in patients with non-Hodgkin lymphomas. Blood 1977; 49: 335
   PubMedGoogle Scholar
• Lapes M., Rosenzweig M., Barbieri B., Joseph R. R., Smalley R. V. Cellular and humoral immunity in non-Hodgkin's lymphoma. Amer. J. clin. Path. 1977; 67: 347
   PubMedGoogle Scholar
• Lennert K. Malignant lymphomas other than Hodgkin's disease. Springer Verlag, Berlin, Heidelberg, New York 1981
   Google Scholar
• Lindemalm C., Biberfeld P., Björkholm M., Holm G., Johansson B., Mellstedt H., Nilsson B, Öst A. Pre-treatment blood lymphocyte abnormalities and prognosis of non-Hodgkin lymphoma patients. 1983, (a), Submitted
   Google Scholar
• Lindemalm C., Biberfeld P., Björkholm M., Holm G., Johansson B., Mellstedt H., Nilsson B, Öst A. Longitudinal studies of blood lymphocyte functions in non-Hodgkin's lymphoma. Eur. J. Cancer Clin. Oncol. 1983; 19: 747, (b)
   PubMedGoogle Scholar
• Lutz W. Statistical methods as applied to immunological data. Handbook of experimental immunology, D. M. Weir. Blackwell Scientific Publications, Oxford 1967; 1163
   Google Scholar
• Misra N. C., Singh V. P., Saxena K. C., Saxena R. P., Agarwal C. G. Cell-mediated immune status in patients of non-Hodgkin's lymphoma. An evaluation by skin tests, blastogenic transformation of lymphocytes and T cell count. Cell Mol. Biol. 1979; 25: 185
   Google Scholar
• Portlock C. S. Management of the indolent non-Hodgkin's lymphomas. Semin. Oncol. 1980; 7: 292
   PubMed Web of Science ®Google Scholar
• Schein P. S., DeVita V. T., Jr, Hubbard S., Chabner B. A., Canellos G. P., Berard C. W., Young R. C. Bleomycin, adriamycin, cyclophosphamide, vincristine and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. Ann. intern. Med. 1976; 85: 417
   PubMed Web of Science ®Google Scholar
• Skarin A. T., Canellos G. P. Chemotherapy of advanced non-Hodgkin's lymphoma. Clin. Haematol. 1979; 8: 667
   PubMedGoogle Scholar
• Streuli R. A., Ultman J. E. Non-Hodgkin's lymphomas. Historical perspective and future prospects. Semin. Oncol. 1980; 7: 223
   PubMedGoogle Scholar
• Wedelin C., Björkholm M., Holm G., Ogenstad S., Mellstedt H. Blood lymphocyte functions in healthy adults in relation to age. Scand. J. Haematol. 1982; 28: 45
   PubMedGoogle Scholar
• Yonkosky D. M., Feldman M. I., Cathcart E. S., Kim S. Improvement of in vitro mitogen proliferation responses in non-Hodgkin's lymphoma patients exposed to fractionable total body irradiation. Cancer 1978; 42: 1204
   PubMedGoogle Scholar